Literature DB >> 21689676

Progesterone prevents depression-like behavior in a model of Parkinson's disease induced by 6-hydroxydopamine in male rats.

Sebastián Casas1, Sebastián García, Ricardo Cabrera, Federico Nanfaro, Carla Escudero, Roberto Yunes.   

Abstract

Hemiparkinsonism induced by 6-hydroxydopamine (6-OHDA) injected in left corpus striatum is a recognized model of motor deficits in rats. Some reports concerning motor deficits indicate a favorable response to steroid administration in hemiparkinsonian animals. However, there is no much information regarding progesterone administration in relation to cognitive and affective dysfunctions. Here we could confirm earlier reports regarding a mild deficit of memory and a noticeable depressive-like behavior 4 weeks after injecting 6-OHDA. We also present some evidence that progesterone could be - when administered 7 days after the injection of 6-OHDA - a possible neuroprotector concerning both motor deficits as well as cognitive - memory- and depression-like behaviors. The affective deficit was reverted by administering the tricyclic antidepressant imipramine. Since Parkinson's disease is a conspicuous cause of psycho-organic decline in human beings, it would be important to be able of dealing early with non-motor indicators in order to use prospective neuroprotectors to prevent the progression of the disease.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21689676     DOI: 10.1016/j.pbb.2011.06.012

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  6 in total

Review 1.  Monoamine reuptake inhibitors in Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox; Jonathan M Brotchie
Journal:  Parkinsons Dis       Date:  2015-02-25

Review 2.  Application of Neurotoxin-Induced Animal Models in the Study of Parkinson's Disease-Related Depression: Profile and Proposal.

Authors:  Ya-Kui Mou; Li-Na Guan; Xiao-Yan Yao; Jia-Hui Wang; Xiao-Yu Song; Yong-Qiang Ji; Chao Ren; Shi-Zhuang Wei
Journal:  Front Aging Neurosci       Date:  2022-05-13       Impact factor: 5.702

Review 3.  Progesterone in the Brain: Hormone, Neurosteroid and Neuroprotectant.

Authors:  Rachida Guennoun
Journal:  Int J Mol Sci       Date:  2020-07-24       Impact factor: 5.923

4.  Progesterone Protects Prefrontal Cortex in Rat Model of Permanent Bilateral Common Carotid Occlusion via Progesterone Receptors and Akt/Erk/eNOS.

Authors:  Miloš Stanojlović; Ivana Guševac Stojanović; Marina Zarić; Jelena Martinović; Nataša Mitrović; Ivana Grković; Dunja Drakulić
Journal:  Cell Mol Neurobiol       Date:  2019-12-21       Impact factor: 5.046

5.  Progesterone Exerts a Neuromodulatory Effect on Turning Behavior of Hemiparkinsonian Male Rats: Expression of 3 α -Hydroxysteroid Oxidoreductase and Allopregnanolone as Suggestive of GABAA Receptors Involvement.

Authors:  Roberto Yunes; Sebastián Casas; Eliana Gaglio; Ricardo Cabrera
Journal:  Parkinsons Dis       Date:  2015-03-31

Review 6.  Understanding the role of steroids in typical and atypical brain development: Advantages of using a "brain in a dish" approach.

Authors:  D Adhya; E Annuario; M A Lancaster; J Price; S Baron-Cohen; D P Srivastava
Journal:  J Neuroendocrinol       Date:  2018-02       Impact factor: 3.627

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.